Aura 2016 Supplementary data

Table S4.9 Mycobacterium tuberculosis notifications and resistance, by jurisdiction, 2014

Jurisdiction	Total TB cases notified to NNDSS	Total isolates tested	Isoniazid,^a % resistant (n)	Rifampicin,^a % resistant (n)	Ethambutol,^a % resistant (n)	Pyrazinamide,^a % resistant (n)	Fluoroquinolones,^bc % resistant (n)	Kanamycin,^b % resistant (n)	Capreomycin,^b % resistant (n)	Amikacin,^b % resistant (n)	Ethionamide/ prothionamide,^b % resistant (n)
ACT	30	22	13.6 (22)	4.5 (22)	0.0 (22)	0.0 (22)	0.0 (1)	0.0 (9)	0.0 (1)	0.0 (1)	0.0 (1)
NSW	472	340	9.7 (340)	1.5 (340)	2.1 (338)	2.4 (336)	20.0 (10)	0.0 (0)	0.0 (7)	0.0 (7)	12.5 (8)
NT	28	22	4.5 (22)	0.0 (22)	0.0 (22)	0.0 (21)	0.0 (1)	0.0 (1)	0.0 (1)	0.0 (1)	0.0 (1)
Qld	165	142	11.4 (140)	4.9 (142)	1.4 (142)	4.2 (142)	11.1 (9)	0.0 (9)	0.0 (8)	0.0 (9)	75.0 (8)
SA	48	40	5.4 (37)	5.0 (40)	0.0 (39)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (2)	0.0 (0)	0.0 (0)
Tas	9	8	0.0 (8)	0.0 (8)	0.0 (8)	12.5 (8)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (0)
Vic	448	347	6.7 (329)	2.0 (347)	0.6 (337)	0.3 (336)	6.1 (33)	11.8 (34)	2.9 (34)	2.9 (34)	35.3 (34)
WA	139	106	7.5 (106)	2.8 (106)	0.9 (106)	3.8 (106)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (0)	0.0 (1)
Australia	1339	1027	8.5 (1004)	2.4 (1027)	1.2 (1014)	2.1 (971)	9.3 (54)	9.1 (44)	1.9 (53)	1.9 (52)	35.8 (53)

ACT = Australian Capital Territory; NNDSS = National Notifiable Diseases Surveillance System; NSW = New South Wales; NT = Northern Territory; Qld = Queensland; SA = South Australia; Tas = Tasmania; TB = tuberculosis; Vic = Victoria; WA = Western Australia

a Routinely tested agents

b Selectively tested agents

c Fluoroquinolones include ciprofloxacin, ofloxacin, moxifloxacin and levofloxacin.

Source: NNDSS snapshot (23 June 2015) 373 and 374